Trading Options with an Edge
Select Page

CCXI

Search by
TICKER SYMBOL

ChemoCentryx Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

16.52

-0.05

(-0.302%)

Volume:

1,789,676

52 week range:

9.53 - 70.29

Market Cap:

1.155B

Company Description:

ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. ChemoCentryx's lead drug candidate, avacopan (CCX168), successfully completed a pivotal Phase III trial in ANCA-associated vasculitis and a New Drug Application is under review by the U.S. Food and Drug Administration. Avacopan is also in late stage clinical development for the treatment of severe Hidradenitis Suppurativa and C3 glomerulopathy (C3G). ChemoCentryx also has early stage drug candidates that target chemoattractant receptors in other inflammatory and autoimmune diseases and in cancer.